Patent details

EP2307456 Title: ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS

Basic Information

Publication number:
EP2307456
PCT Application Number:
PCT/US/2009/048514
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097709653
PCT Publication Number:
WO/2009/158432
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS
French Title of Invention:
INHIBITION DE L ANG-2 POUR TRAITER LA SCLÉROSE EN PLAQUES
German Title of Invention:
DIE INHIBIERUNG VON ANG-2 ZUR BEHANDLUNG MULTIPLER SKLEROSE
SPC Number:

Dates

Filing date:
24/06/2009
Grant date:
15/10/2014
EP Publication Date:
15/10/2014
PCT Publication Date:
30/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/04/2011
EP B1 Publication Date:
15/10/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/06/2015
Expiration date:
24/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/06/2009
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, United States (US)

Inventor

1

Name:
KIRCHNER Jacqueline, A.
Address:
United States (US)

2

Name:
MUSTELIN Tomas, Mikael
Address:
United States (US)

Priority

Priority Number:
76431 P
Priority Date:
27/06/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/22;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages